Latest news
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTCRMC in Crosby Plays Pivotal Role in Type 2 Diabetes Treatment Study - Lakeland PBSLakeland PBS · Fri, 07 Aug 2026 05:21:18 GMTFDA Approves Orezeyful for Narcolepsy Type 1 in Adults - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 15:12:46 GMTFDA Approves First Drug To Treat Narcolepsy Type 1 Symptoms - RTTNewsRTTNews · Thu, 06 Aug 2026 12:14:00 GMTTakeda’s Orzeyful approved in US as first-in-class orexin treatment for narcolepsy Type 1 - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Thu, 06 Aug 2026 10:35:42 GMTU.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 - Business WireBusiness Wire · Wed, 05 Aug 2026 22:10:00 GMTFDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms - Psychiatric TimesPsychiatric Times · Wed, 05 Aug 2026 20:45:21 GMTToxicity Considerations With Third-Line Treatment in KRAS Wild-Type mCRC - Targeted OncologyTargeted Oncology · Fri, 31 Jul 2026 21:16:29 GMT